News summary

[Enhua Pharmaceutical: Obtained the "Drug Registration Certificate" for Lacosamide Injection] Securities Times e Company News, Enhua Pharmaceutical (002262) announced on the evening of May 23 and was recently approved and issued by the State Drug AdministrationwreckitralpharcadegameLacosamide injectionwreckitralpharcadegame"Drug Registration Certificate", pullwreckitralpharcadegame.wreckitralpharcadegame..

Newsletter text

[Enhua Pharmaceutical: Obtained the "Drug Registration Certificate" of Lacosamide Injection] Securities Times e Company News, Enhua Pharmaceutical (002262) announced on the evening of May 23 that it was recently approved and issued by the State Food and Drug Administration. The "Drug Registration Certificate" of Lacosamide Injection is suitable for the combined treatment of partial seizures in patients aged 4 and above.